The Comparison of the Cardiovascular Effects of Remifentanil and Nitroprusside for Controlled Hypotension

Trial Profile

The Comparison of the Cardiovascular Effects of Remifentanil and Nitroprusside for Controlled Hypotension

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Dec 2013

At a glance

  • Drugs Remifentanil (Primary) ; Sodium nitroprusside (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 11 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top